πŸ‡ΊπŸ‡Έ FDA
Patent

US 8691872

Dispersions of rasagiline citrate

granted A61KA61K31/135A61K31/205

Quick answer

US patent 8691872 (Dispersions of rasagiline citrate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/135, A61K31/205, A61K47/32, A61K9/1635